Skip to main content
Premium Trial:

Request an Annual Quote

Tempus, ASCO Partner to Facilitate Recruiting for TAPUR Trial

NEW YORK (GenomeWeb) – The American Society of Clinical Oncology and precision medicine firm Tempus have agreed to work together in support of ASCO's Targeted Agent and Profiling Utilization (TAPUR) Study.

Under the agreement, clinicians who order the company's 596-gene Tempus xT assay will now receive a report that has been "optimized for TAPUR participation" with a specific summary of the genomic alterations targeted by study drugs. This will hopefully help clinical sites using Tempus' assay more quickly identify and screen patients who may be eligible for the trial.

TAPUR is a prospective, non-randomized clinical trial measuring the safety and efficacy of multiple US Food and Drug Administration-approved, molecularly targeted drugs in advanced patients who test positive for a target biomarker via a test performed by a CLIA-certified, CAP-accredited lab. To date, more than 1,700 participants have consented to participate, and more than 1,220 have been treated with a TAPUR study drug, according to ASCO.

"One of the goals of Tempus is to gather as much information as possible regarding efficacy of targeted therapies in specific clinical situations and we are pleased to offer this report to support the goals of the TAPUR study," Tempus Chief Medical officer Gary Palmer said in a statement.

"The optimized Tempus report will help TAPUR clinical sites determine who is eligible in a more expedited manner," added ASCO's Richard Schilsky, principle investigator of the TAPUR Study.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.